Skip to main content
. 2019 Dec;11(12):5290–5299. doi: 10.21037/jtd.2019.11.51

Table 3. Biopsy diagnostic failure of anterior mediastinal masses (AMMs) (11 cases).

Diagnostic failure classification Age/sex Lesion size (cm) Biopsy diagnosis Final diagnosis (method)
Insufficiency for subclassification 29/female 6 Low malignance Thymoma (surgery)
47/male 14.8 Carcinoma Thymic carcinoma (clinical comprehensive diagnosis)
29/male 14.8 Suspected lymphoma Diffuse large B cell lymphoma (surgery)
38/female1 10.7 Suspected lymphohematopoietic tumor T-lymphoblastic lymphoma (bone marrow biopsy + flow cytometry)
Tumor necrosis 44/female 10 Necrotic tissue Neuroendocrine carcinoma** (FNAC+ clinical comprehensive diagnosis)
Misdiagnosis 38/female2 10.7 Granulocytic sarcoma T-lymphoblastic lymphoma (bone marrow biopsy + flow cytometry)
Non-diagnosis 58/female 5.9 Pulmonary tissue with fibrous tissue proliferation and lymphocyte infiltration Lung squamous cell carcinoma (bronchoscopy)
18/male 7 Pseudostratified ciliated columnar epithelium Mixed germ cell tumor (surgery)
48/male 10 Little skin, striated muscle and lymphoid tissue Thymoma (FNAC)
25/female 11 Atypical lymphocyte PMLBCL (secondary CEUS-guided biopsy)
45/male* 8.8 Inflammatory cell infiltration and foam cell reaction in pulmonary tissue Hodgkin lymphoma (bronchoscopy)

1,2, the same patient underwent two ultrasound-guided biopsies in one month; *, core needle biopsy guided by contrast enhanced ultrasound; **, re-biopsy after chemoradiotherapy of neuroendocrine carcinoma. PMLBCL, primary mediastinal large B cell lymphoma; FNAC, fine needle aspiration biopsy.